Boron Nitride Nanotubes in Nanomedicine Market Statistics 2030:
Boron nitride nanotube has a nanostructure that is similar to carbon nanotubes, where boron and nitrogen atoms are arranged in hexagons. This type of nanotube is a polymorph of boron nitride and is known to be the strongest lightweight nanomaterial. In addition, when compared to carbon nanotubes, boron nitride nanotubes are found to have higher thermal stability. They possess higher polarizability and electrical insulation, a wider bandgap, a higher neutron absorption cross-section, and higher transparency than carbon nanotubes. Boron nitride nanotubes are used in nanomedicine as drug carriers in therapies related to conditions such as cancer and also as magnetic resonance imaging (MRI) contrast agents.
Impact of COVID-19 on the Medical Device Market:
COVID-19 is an infectious disease that originated in the Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.
Increase has been witnessed in the demand for medical supplies to take care of the infected population. Respiratory support devices such as atomizers, life support machines, oxygen generators, and monitors are among the majorly used medical devices in primary clinical treatment. Moreover, COVID-19 has led to a huge surge in demand for medical supplies such as personal protective equipment including masks, gloves, and protective eyeglasses. The need for medical supplies has increased among both from healthcare professionals and the civil population for precautionary measures, owing to rise in the number of COVID-19 cases worldwide. Manufacturers of these products have a chance to capitalize on this increased demand for medical supplies to ensure an adequate and continuous supply of personal protective equipment in the market. Therefore, COVID 19 is expected to have a significant impact on the boron nitride nanotubes market.
Top Impacting Factors
Rise in demand for the treatment of neurological conditions such as Parkinson's disease and Alzheimer's disease fuels the demand for boron nitride nanotubes in nanomedicine market.
In Parkinson's disease and Alzheimer's disease, there is often a chance of insufficient absorption of drugs taken orally. With boron nitride nanotubes, this absorption can be improved with at-site drug administration.
In addition, rise in usage of nanomedicine in drug delivery technology is a significant factor that has been driving the market.
However, high cost of nanotube drug therapies and risks of improper drug delivery are some of the factors that can restrain the boron nitride nanotubes in nanomedicine market growth.
Key Market Trends
Leading manufacturers of boron nitride nanotubes in nanomedicine are focused on developing customized solutions for the needs of patients.
The 90–98% purity segment of these nanotubes is anticipated to hold a significant share of the market. This is attributed to rise in consumption of boron nitride nanotubes in specialty centers.
Asia-Pacific is expected to grow at a higher growth rate during the forecast period. This is attributed to rise in demand for prophylaxis of life-threatening diseases and increase in the number of research grants in Asia-Pacific.
In North American, nanomedicine start-ups are entering into partnership with enterprises operating herein. Hence, this region leads the boron nitride nanotubes in nanomedicine market.
Key Benefits of the Report
- This study presents the analytical depiction of the boron nitride nanotubes industry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of the boron nitride nanotubes in nanomedicine market share.
- The current market is quantitatively analyzed to highlight the boron nitride nanotubes in nanomedicine market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed boron nitride nanotubes in nanomedicine market analysis depending on competitive intensity and how the competition will take shape in the coming years.
Questions Answered in the Global Boron Nitride Nanotubes Market Report
- Which are the leading players active in the boron nitride nanotubes market?
- How is each segment of the market expected to grow ?
- What are the adoption trends for boron nitride nanotubes in emerging economies and established economies across the world?
- What are the current trends that will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities of the market?
- What future projections would help in taking further strategic steps?
- What are boron nitride nanotubes?
- What is the boron nitride nanotubes market prediction in the future?
- What are the current trends and predicted trends?
Boron Nitride Nanotubes in Nanomedicine Market Report Highlights
| Aspects | Details |
 By Modality |
|
 By Indication |
|
 By Application |
|
 By End User |
|
 By Region |
|
 Key Market Players | Pfizer Inc., Novartis AG, Celgene Corporation, Gilead Sciences, Inc., AstraZeneca, Teva Pharmaceutical Industries Ltd., Cadila Pharmaceuticals., Amgen Foundation, Inc., Johnson & Johnson Services, Inc., Abbott |
Loading Table Of Content...
